The Avicenna Alliance is proud to announce the newest addition to its list of members: SmartCatch!

SmartCatch is a deeptech start-up with disruptive technological know-how. Located at the heart of the Toulouse Oncopole, the start-up intends to provide oncology research and treatment centres with a series of cutting-edge microtechnology-based devices that can be used in clinical routine to isolate blood-based biomarkers for longitudinal monitoring of cancerous pathology and customization of the therapeutic strategy.

SmartCatch's core innovation relies on 3D microdevices integrated to customized fluid management platforms for the mild capture of circulating tumor cells (CTC) from whole blood exploiting their physical traits while preserving their native state and improving their representativeness in clinical routine. The company's conviction is to access the clinical market offering dedicated products enabling the implementation of precision medicine at affordable costs with a higher degree of uniformity and standardization, contributing to a principle of equity in healthcare.

More information about SmartCatch can be found here